Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Sees Large Increase in Short Interest

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) saw a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 14,400 shares, an increase of 585.7% from the October 31st total of 2,100 shares. Based on an average daily volume of 14,300 shares, the short-interest ratio is presently 1.0 days.

Reviva Pharmaceuticals Trading Up 22.9 %

Shares of Reviva Pharmaceuticals stock traded up $0.04 on Thursday, reaching $0.23. 100 shares of the stock were exchanged, compared to its average volume of 16,188. The business has a 50 day moving average price of $0.14 and a two-hundred day moving average price of $0.18. Reviva Pharmaceuticals has a twelve month low of $0.07 and a twelve month high of $1.62.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.